This is the protocol for a review and there is no abstract. The objectives are as follows:
To establish the efficacy and safety of botulinum toxin aimed at improving UOS dysfunction in people with non progressive and progressive neurological disease.
To provide the best evidence to inform clinical practice.
To assist with future research planning.